Robots for diagnostics and surface sanitation, a chat-bot integrated into the MOH’s online portal for providing public consulting support during the pandemic, contactless terminal for body temperature measurement, pass control management platform to be...
Even in the most optimistic scenario, the coronavirus disease outbreak in the Russian Federation will last for at least two months, Georgii Bazykin, Skoltech Professor, Chair of the Molecular Evolution Sector, IITP RAS, believes According to his forecast...
The final phase of the corporate acceleration program that has been co-run by Skolkovo Foundation and international biopharmaceutical company AstraZeneca is now complete The representatives of six corporate winners speak about their developments. Natalia...
An innovative domestically developed device for extracorporeal blood purification has been registered in Russia: appropriate permit for clinical administration was issued by the Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor) This medical...
Skolkovo resident company 3D Bioprinting Solutions has become the first company to use a 3D printer to create live tissue in space, printing an organ construct for the thyroid gland of a mouse on board the International Space Station (ISS) this month. ...
The fifth Pharma’s Cool educational programme for students and young entrepreneurs began on Monday at the Skolkovo Technopark. Organised by the Skolkovo Foundation’s biomed cluster and Open University Skolkovo (OPUS), Pharma’s Cool aims...
A new drug for HIV patients developed by Skolkovo resident Viriom has been included on Russia’s list of vital and essential drugs (VED), meaning it will be available to patients and doctors across Russia under both federally and regionally funded programmes...
Rusbase, an independent website devoted to technology, business and investment, published a list on Tuesday of the top five most interesting biotech startups in Russia, and all are residents of the Skolkovo Foundation. An ExoAtlet pilot demonstrates the...
Few countries in the world can benefit from telemedicine and the remote diagnosis and monitoring services it offers as much as Russia, with its enormous territory and multitude of sparsely populated and hard to reach areas. Yet currently, digital healthcare...
Skolkovo resident startup Motorica , which makes prostheses for both children and adults, was awarded a special prize by Russia’s Channel One on Thursday. Konstantin Deblikov (left) tests a prototype adult hand as Motorica CEO Ilya Chekh looks on...
Twenty Skolkovo biomed startups are heading to the 2018 BIO International Convention in Boston this week to showcase their innovations at one of the world’s biggest biotech events. Twenty-six Skolkovo resident startups are taking part in BIO 2018...
The Skolkovo Foundation has joined forces with the U.K.’s AMR Centre, a private-public initiative launched in 2016 to support and accelerate the development of new antibiotics, to combat the global problem of antimicrobial resistance. Skolkovo's...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
The directors of three Skolkovo startups won awards at two ceremonies this week for their innovative tech developments. Group-IB head Ilya Sachkov at a previous EY awards ceremony. Photo: EY. Ilya Sachkov, head of the cybersecurity company Group...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
A large section of the Skolkovo Technopark was turned into an obstacle course with a difference this week, as people of all ages raced to complete a course that included walking up some steps while holding a tray of apples, opening a door at the top of the...
The first shared lab space in Russia for life sciences and biotech startups opened its doors at the Skolkovo Technopark on Wednesday with a mission to help budding biomed entrepreneurs test their theories and turn their ideas into a commercial company. ...
The Golden Autumn agricultural trade fair is to a large extent a celebration of Russian traditions. Individual regions of Russia present their local produce on their own stand, often accompanied by people dressed in folk costumes who sing, dance or play traditional...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
UNIM , a resident startup of the Skolkovo Foundation’s biomed cluster that provides remote cancer diagnosis services, has raised investment from Medme, a strategic investor on the digital medicine market. Under the terms of the deal, the details of which...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
The Skolkovo Foundation announced the official launch of Skolkovo Ventures – three new investment funds devoted to IT, industrial technology and biotech – at the Startup Village open-air conference on Tuesday. The investment funds have been set...
SL Onkolodzhi , a Skolkovo resident startup working on a cancer vaccine, has successfully completed phase I/IIa clinical trials together with its U.S. partner, CureLab Oncology, Inc . The two companies have developed a cancer vaccine called Elenagen™...
Half of all Russian-origin innovative pharmaceuticals are developed by Skolkovo Foundation startups, Kirill Kaem, head of the organisation’s biomed cluster, told a meeting of the foundation’s council on Monday evening. Of about 1,400 pharmaceuticals...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...